Publication

Article

CURE

Fall 2009
Volume8
Issue 3

Treatment Snapshot

Treatment for cancer treatment-related hot flashes.

Management solutions for cancer treatment-related hot flashes include:

>

Catapres (clonidine)

>

Effexor (venlafaxine)

>

Neurontin (gabapentin)

>

Paxil (paroxetine)*

>

Prozac (fluoxetine)*

*may reduce effectiveness of tamoxifen

Articles in this issue
Web Exclusive: Quiz: Do You Know the Recommended Screening Guidelines?
Web Exclusive: When is Multidisciplinary Care Really Needed?
The Internal Flame
Message from the Editor
Letters from Our Readers
Overheated
I Laughed
Kidney Cancer & Lung Cancer
Cancer Screening
Life Preserver?
Teen Tribulations
Breast Cancer Around the World
Deconstructing Grief
Big Tobacco, Meet the FDA
A Lion, An Angel, and a Pioneer

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Content
Image of hand.
June 10th 2025

Oncology Nurse Amanda Snyder Turns Personal Experience Into Advocacy

Jeanine Pronio
Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
June 7th 2025

Utilizing AI in Prostate Cancer Care and Management

Alex Biese
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine in advanced kidney cancer: © stock.adobe.com.
June 6th 2025

Personalized Vaccine Elicits Responses in Patients With Kidney Cancer

Alex Biese
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced kidney cancer.
New treatment combinations are transforming genitourinary cancer care: © stock.adobe.com.
May 30th 2025

Rapid Developments to Enhance Patient Experience in GU Cancer

Dr. John L. Gore
New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq: © stock.adobe.com
May 30th 2025

Additive Antihistamines May Improve Metastatic Bladder Cancer Outcomes

Alex Biese
Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq.
A powerful new ally is emerging in cancer care: artificial intelligence: © stock.adobe.com.
May 27th 2025

The Dawn of AI in Prostate Cancer Care

Mike Hennessy Jr.
A powerful new ally is emerging in cancer care: artificial intelligence.